Find clinical trials for Diabetes in Baltimore, MD
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Baltimore, MD, USA:
Use Dapagliflozin 10 mg, Saxagliptin 5 mg, Metformin 500 mg treat type 2 diabetes patients with controlled cancers...
Phase 2, Phase 3
Rockville, Maryland, United States
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Baltimore, Maryland, United States and 43 other locations
This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes...
Phase 2
Burke, Virginia, United States and 16 other locations
African American Veterans with albuminuric stage 2 and 3 chronic diabetic kidney disease (DKD), using Empagliflozin or Finerenone or combina...
Phase 4
Washington D.C., District of Columbia, United States
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Baltimore, Maryland, United States and 24 other locations
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...
Phase 3
Beltsville, Maryland, United States and 217 other locations
This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...
Phase 2
Silver Spring, Maryland, United States and 47 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
Takoma Park, Maryland, United States and 89 other locations
with type 2 diabetes (T2D)....
Washington, District of Columbia, United States
The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on:*...
Phase 3
Columbia, Maryland, United States and 115 other locations
Clinical trials
Research sites
Resources
Legal